![](/img/cover-not-exists.png)
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stilgenbauer, Stephan, Eichhorst, Barbara, Schetelig, Johannes, Coutre, Steven, Seymour, John F, Munir, Talha, Puvvada, Soham D, Wendtner, Clemens-Martin, Roberts, Andrew W, Jurczak, Wojciech, MulligaLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(16)30019-5
Date:
May, 2016
File:
PDF, 324 KB
english, 2016